Monday, July 20, 2015 11:42:40 PM
FINRA short sales of CTIX
20150720|CTIX|519776|0|872941|O
60% of today's volume was short sales!
Go CTIX!!! -AlanC
I point you to this post which I quote below:
Congratulations. You have just entered the Twilight Zone.
Short volume reporting is of no value to investors. In spite of its irrelevance it is regularly used by message board posters to excuse poor price performance by whatever company needs it.
Real short selling, as in the borrowing of shares and selling them with the intent of purchasing cheaper shares at some future date to replace those borrowed, does not weigh on the price of CTIX in any material way. Look at the twice a month Finra Equity Short Interest report for CTIX and compare it to other developing stage stage biopharmaceutical companies and you should reach the same conclusion.
http://otce.finra.org/ESI
The archived short interest data as reported at the following link show that there has been little change in the CTIX data since the beginning of the year in spite of the share price fluctuations.
http://www.otcmarkets.com/stock/CTIX/short-sales
You would be wise to avoid facilitating the use of Short Sale Volume Reporting here. Don't be fooled. -loanranger
"Games are won by players who focus on the playing field -- not by those whose eyes are glued to the scoreboard." - Warren Buffett
